Cited 19 time in
- Title
- Non-toxic sulfur inhibits LPS-induced inflammation by regulating TLR-4 and JAK2/STAT3 through IL-6 signaling
- Author(s)
- D Y Kang; N Sp; E S Jo; A Rugamba; H D Kim; I H Kim; Jong-Chan Park; S W Bae; K J Jang; Y M Yang
- Bibliographic Citation
- Molecular Medicine Reports, vol. 24, no. 1, pp. 485-485
- Publication Year
- 2021
- Abstract
- Janus kinase 2 (JAK2) and STAT3 signaling is considered a major pathway in lipopolysaccharide (LPS)-induced inflammation. Toll-like receptor 4 (TLR-4) is an inflammatory response receptor that activates JAK2 during inflammation. STAT3 is a transcription factor for the pro-inflammatory cytokine IL-6 in inflammation. Sulfur is an essential element in the amino acids and is required for growth and development. Non-toxic sulfur (NTS) can be used in livestock feeds as it lacks toxicity. The present study aimed to inhibit LPS-induced inflammation in C2C12 myoblasts using NTS by regulating TLR-4 and JAK2/STAT3 signaling via the modulation of IL-6. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was conducted to analyze cell viability and reverse transcription polymerase chain reaction and western blotting performed to measure mRNA and protein expression levels. Chromatin immunoprecipitation and enzyme-linked immunosorbent assays were used to determine the binding activity of proteins. The results indicated that NTS demonstrated a protective effect against LPS-induced cell death and inhibited LPS-induced expression of TLR-4, JAK2, STAT3 and IL-6. In addition, NTS inhibited the expression of nuclear phosphorylated-STAT3 and its binding to the IL-6 promoter. Therefore, NTS may be a potential candidate drug for the treatment of inflammation.
- Keyword
- Non-toxic sulfurToll-like receptor 4Janus kinase 2STAT3IL-6
- ISSN
- 1791-2997
- Publisher
- Spandidos Publ Ltd
- Full Text Link
- http://dx.doi.org/10.3892/mmr.2021.12124
- Type
- Article
- Appears in Collections:
- 1. Journal Articles > Journal Articles
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.